Paul Lammers

Company: Triumvira Immunologics

Job title: President & Chief Executive Officer

Seminars:

Clinical Trial Updates for TAC Technology 3:30 pm

Elucidating the difference between TAC technology and other cell therapies Providing updates of clinical developments Using clinical to data to inform the future of phase I and II trialsRead more

day: Day Two